Cargando…

Evidence from an In Vitro Study: Is Oxacillin Plus Vancomycin a Better Choice for Heteroresistant Vancomycin-Intermediate Staphylococcus aureus?

INTRODUCTION: Heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) bacteremia may result in clinical failure of vancomycin therapy, together with prolonged infection and hospitalization. This clinical problem has resulted in a search for more effective treatment options. The current...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bakthavatchalam, Yamuna Devi, Ralph, Ravikar, Veeraraghavan, Balaji, Babu, Priyanka, Munusamy, Elakkiya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374240/ https://www.ncbi.nlm.nih.gov/pubmed/30460607 http://dx.doi.org/10.1007/s40121-018-0224-z

Ejemplares similares

Genomic insights on heterogeneous resistance to vancomycin and teicoplanin in Methicillin-resistant Staphylococcus aureus: A first report from South India
por: Bakthavatchalam, Yamuna Devi, et al.
Publicado: (2019)

Novel Observations in 11 Heteroresistant Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Strains from South India
por: Bakthavatchalam, Yamuna Devi, et al.
Publicado: (2016)

Vancomycin heteroresistance in Staphylococcus haemolyticus: elusive phenotype
por: Bathavatchalam, Yamuna Devi, et al.
Publicado: (2021)

Molecular epidemiology of heteroresistant vancomycin-intermediate Staphylococcus aureus in Brazil
por: Silveira, Alessandro Conrado de Oliveira, et al.
Publicado: (2015)

Vancomycin Heteroresistance in Methicillin-resistant Staphylococcus aureus, Taiwan
por: Wang, Jiun-Ling, et al.
Publicado: (2004)

Heteroresistant Vancomycin Intermediate Coagulase Negative Staphylococcus in the NICU: A Systematic Review
por: Chong, Jasmine, et al.
Publicado: (2016)

Vancomycin and Oxacillin Co-Resistance of Commensal Staphylococci
por: Soyege, Ariyo Oludotun, et al.
Publicado: (2014)

Clinical, Microbiological, and Genetic Characteristics of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus Bacteremia in a Teaching Hospital
por: Di Gregorio, Sabrina, et al.
Publicado: (2015)

Typhoid fever: issues in laboratory detection, treatment options & concerns in management in developing countries
por: Veeraraghavan, Balaji, et al.
Publicado: (2018)

Clinical and Microbiological Characteristics of Heteroresistant and Vancomycin-Intermediate Staphylococcus aureus from Bloodstream Infections in a Brazilian Teaching Hospital
por: da Costa, Thaina Miranda, et al.
Publicado: (2016)

Molecular Events for Promotion of Vancomycin Resistance in Vancomycin Intermediate Staphylococcus aureus
por: Hu, Qiwen, et al.
Publicado: (2016)

Evolving Rapid Methicillin-resistant Staphylococcus aureus Detection: Cover All the Bases
por: Bakthavatchalam, Yamuna Devi, et al.
Publicado: (2017)

In vitro activity of recombinant lysostaphin in combination with linezolid, vancomycin and oxacillin against methicillin-resistant Staphylococcus aureus
por: Narasimhaswamy, Nagalakshmi, et al.
Publicado: (2017)

Systematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates
por: Zhang, Shanshan, et al.
Publicado: (2015)

Laboratory Detection and Clinical Implication of Oxacillinase-48 like Carbapenemase: The Hidden Threat
por: Bakthavatchalam, Yamuna Devi, et al.
Publicado: (2016)

Vancomycin heteroresistance among methicillin-resistant clinical isolates S. haemolyticus, S. hominis, S. simulans, and S. warneri
por: Szemraj, Magdalena, et al.
Publicado: (2022)

Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis
por: Shariati, Aref, et al.
Publicado: (2020)

Draft Genome Sequences of Vancomycin-Susceptible Staphylococcus aureus Related to Heterogeneous Vancomycin-Intermediate S. aureus
por: Ramaraj, Thiruvarangan, et al.
Publicado: (2014)

Novel single-nucleotide variations associated with vancomycin resistance in vancomycin-intermediate Staphylococcus aureus
por: Lin, Lee-Chung, et al.
Publicado: (2018)

Plectranthus amboinicus essential oil and carvacrol bioactive against planktonic and biofilm of oxacillin- and vancomycin-resistant Staphylococcus aureus
por: Vasconcelos, Sara Edwirgens Costa Benício, et al.
Publicado: (2017)

Orally Administered Amoxicillin/Clavulanate: Current Role in Outpatient Therapy
por: Veeraraghavan, Balaji, et al.
Publicado: (2020)

Oral Antibiotics in Clinical Development for Community-Acquired Urinary Tract Infections
por: Veeraraghavan, Balaji, et al.
Publicado: (2021)

In-Vitro Selection of Ceftazidime/Avibactam Resistance in OXA-48-Like-Expressing Klebsiella pneumoniae: In-Vitro and In-Vivo Fitness, Genetic Basis and Activities of β-Lactam Plus Novel β-Lactamase Inhibitor or β-Lactam Enhancer Combinations
por: Palwe, Snehal, et al.
Publicado: (2021)

Reconstruction of the Vancomycin-Susceptible Staphylococcus aureus Phenotype From a Vancomycin-Intermediate S. aureus XN108
por: Peng, Huagang, et al.
Publicado: (2018)

Complete Reconstitution of the Vancomycin-Intermediate Staphylococcus aureus Phenotype of Strain Mu50 in Vancomycin-Susceptible S. aureus
por: Katayama, Yuki, et al.
Publicado: (2016)

Vancomycin Heteroresistance Is Associated with Reduced Mortality in ST239 Methicillin-Resistant Staphylococcus aureus Blood Stream Infections
por: van Hal, Sebastiaan J., et al.
Publicado: (2011)

Comparative Analysis of Virulence and Toxin Expression of Vancomycin-Intermediate and Vancomycin-Sensitive Staphylococcus aureus Strains
por: Jin, Ye, et al.
Publicado: (2020)

Effect of a Point Mutation in mprF on Susceptibility to Daptomycin, Vancomycin, and Oxacillin in an MRSA Clinical Strain
por: Chen, Feng-Jui, et al.
Publicado: (2018)

1656. Evaluation of Using Oxacillin versus Vancomycin for Empiric Therapy of Late-Onset Neonatal Sepsis in NICU
por: Lien, Tsung-Chi, et al.
Publicado: (2023)

Characterization of Infections with Vancomycin-Intermediate Staphylococcus aureus (VISA) and Staphylococcus aureus with Reduced Vancomycin Susceptibility in South Korea
por: Park, Jung Wan, et al.
Publicado: (2019)

Vancomycin (VAN) Combinations with Β-Lactams (BLs) against Methicillin-Resistant Staphylococcus aureus (MRSA), Heterogeneous Intermediate-Level Resistance to Vancomycin (hVISA) and Vancomycin-Intermediate Staphylococcus aureus (VISA)
por: Tran, Kieu-Nhi, et al.
Publicado: (2017)

The Role of β-Glycosylated Wall Teichoic Acids in the Reduction of Vancomycin Susceptibility in Vancomycin-Intermediate Staphylococcus aureus
por: Hort, Michael, et al.
Publicado: (2021)

Emergence of Vancomycin-Intermediate Staphylococcus aureus and S. sciuri, Greece
por: Tsakris, Athanassios, et al.
Publicado: (2002)

721 Decreasing Prevalence of Vancomycin-Heteroresistance (hVISA) among Methicillin-Resistant Staphylococcus aureus (MRSA) Blood Isolates over 10 years: Potential Impact of Vancomycin Treatment Guidelines
por: Khatib, Riad, et al.
Publicado: (2014)

Draft Genome Sequence of Vancomycin-Heteroresistant Staphylococcus epidermidis Strain UC7032, Isolated from Food
por: Gazzola, Simona, et al.
Publicado: (2013)

Genetic Basis of Emerging Vancomycin, Linezolid, and Daptomycin Heteroresistance in a Case of Persistent Enterococcus faecium Bacteremia
por: Chacko, Kieran I., et al.
Publicado: (2018)

Vancomycin and daptomycin minimum inhibitory concentration distribution and occurrence of heteroresistance among methicillin-resistant Staphylococcus aureus blood isolates in Turkey
por: Sancak, Banu, et al.
Publicado: (2013)

Can fosfomycin be an alternative therapy for infections caused by E. coli harbouring dual resistance: NDM and four-amino acid insertion in PBP3?
por: Bakthavatchalam, Yamuna Devi, et al.
Publicado: (2023)

Comparative Genomics Identifies Novel Genetic Changes Associated with Oxacillin, Vancomycin and Daptomycin Susceptibility in ST100 Methicillin-Resistant Staphylococcus aureus
por: Di Gregorio, Sabrina, et al.
Publicado: (2023)

A vancomycin resistance-associated WalK(S221P) mutation attenuates the virulence of vancomycin-intermediate Staphylococcus aureus
por: Rao, Yifan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vrgop2otqds2p91m1iqufofsid